Skip to main content
Top

Clinical and Translational Oncology

Issue 5/2002

Content (11 Articles)

Editorial

Prostate cancer: the great unknown

L. Martínez-Piñeiro

Revisiones

Prostate cancer and the androgen receptor gene

Domingo Navarro Bosch, Juan J. Cabrera Galván, Nicolás Chesa Ponce, B. Nicolás Díaz-Chico

Revisiones

Aspectos clínicos de la biología molecular del cáncer de próstata

Diana González-Espinosa, Miguel A. Jiménez Ríos, Andrés A. Gutiérrez-López

Originales

Cisplatin-based chemotherapy and hyperfractionated radiotherapy for stage III non-small cell lung cancer: survival and patterns of failure after long follow-up

Martín Tejedor Gutiérrez, Juan José Valerdi Álvarez, Begoña Bermejo Fraile, Juan Ignacio Arraras Urdaniz, Ruth Vera García, Francisco Molina Rosillo, Juan José Albistur Tomé

Originales

A comparative study of HER2/neu amplification and overexpression using fluorescencein situ hybridization (FISH) and immunohistochemistry (IHC) in 101 breast cancer patients

Marta Salido, Francesc Solé, Ignasi Tusquets, Josep M. Corominas, Blanca Espinet, MaLluïsa Mariñoso, Teresa Baró, MaCarmen Vela, Xavier Fabregat, Sergi Serrano

Originales

Respuesta terapéutica a gemcitabina en cáncer de mama avanzado en relación con factores immunohistoquímicos

Raquel Gerson, Alberto Serrano, Alberto Villalobos, Ivonne Álvarez, Carlos Ortiz Hidalgo, Ernesto Sánchez Forgach

Originales

Factors involved in morbidity and mortality of total gastrectomy for gastric cancer

Álvaro Díaz de Liaño Argüelles, Miguel Ángel Ciga Lozano, Fabiola Oteiza Martínez, Miguel Aizcorbe Garralda, Francisco Cobo Huici, Ramón Trujillo Ascanio

Notas Clínicas

A case of biliary adenofibroma of the liver causing elevated serum CA 19-9 levels

Ana Lilia Garduño-López, Ricardo Mondragón-Sánchez, Rigoberto Bernal-Maldonado, Carlos A. Hinojosa-Becerril, Abelardo Meneses-García

Notas Clínicas

Masa pancreática como presentación de recaída de cáncer de pulmón no microcítico

Pedro Pérez Segura, Carmen Perezagua Marín, Luis Ortega Medina, Eduardo Díaz-Rubio García

Sección Docente

Radioprotectors

Carmen González San Segundo, Felipe A. Calvo Manuel

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine